Loadingā€¦

Dietary trans fatty acids: Review of recent human studies and food industry responses

Dietary trans FA at sufficiently high levels have been found to increase low density lipoprotein (LDL)-cholesterol and decrease high density lipoprotein (HDL)-cholesterol (and thus to increase the ratio of LDL-cholesterol/HDL-cholesterol) compared with diets high in cis monounsaturated FA or PUFA. T...

Full description

Saved in:
Bibliographic Details
Published in:Lipids 2006-11, Vol.41 (11), p.967-992
Main Author: Hunter, J. Edward
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353
cites cdi_FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353
container_end_page 992
container_issue 11
container_start_page 967
container_title Lipids
container_volume 41
creator Hunter, J. Edward
description Dietary trans FA at sufficiently high levels have been found to increase low density lipoprotein (LDL)-cholesterol and decrease high density lipoprotein (HDL)-cholesterol (and thus to increase the ratio of LDL-cholesterol/HDL-cholesterol) compared with diets high in cis monounsaturated FA or PUFA. The dietary levels of trans FA at which these effects are easily measured are around 4% of energy or higher to increase LDL-cholesterol and around 5 to 6% of energy or higher to decrease HDL-cholesterol, compared with essentially trans-free control diets. Very limited data at lower levels of intake (less than 4% of energy) are available. Most health professional organizations and some govemments now recommend reduced consumption of foods containing trans FA, and effective January 1, 2006, the U.S. Food and Drug Administration requires the labeling of the amounts of trans FA fer serving in packaged foods. In response, the food industry is working on ways to eliminate or greatly reduce trans FA in food products. Current efforts focus on four technological options: (i) modification of the hydrogenation process, (ii) use of interesterification, (iii) use of fractions high in solids from natural oils, and (iv) use of trait-enhanced oils. Challenges to the food industry in replacing trans FA in foods are to develop formulation options that provide equivalent functionality, are economically feasible, and do not greatly increase saturated FA content.
doi_str_mv 10.1007/s11745-006-5049-y
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68307370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68307370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353</originalsourceid><addsrcrecordid>eNqFkc1rFDEYh4Modlv9A7xo8OBt9M3ka-KttFYLC4q655DJh6bszqx5Zyzz35syC4IXTyHwPD_CE0JeMHjLAPQ7ZEwL2QCoRoIwzfKIbJiUXWM46MdkA9CKRrTAzsg54l29MmHkU3LGdKt4a7oN2V3nOLmy0Km4AWly07RQ53PA9_Rr_J3jPR0TLdHHYaI_54MbKE5zyBGpGwJN4xhoHsKMU90oEY_jgBGfkSfJ7TE-P50XZHfz4fvVp2b7-ePt1eW28dx0uumlNwpSJx3nxkASxmjmvDMOotGh6xVTLe-F74PnOug2mOiDb6VQqk9c8gvyZt09lvHXHHGyh4w-7vduiOOMVnU1BNdQwdf_gHfjXIb6NttqoSUAmAqxFfJlRCwx2WPJhxrHMrAPwe0a3Nbg9iG4Xarz8jQ894cY_hqnwhXQK3Cf93H5_6Ld3n65BqN0NV-tZnKjdT9KRrv7Vj-TV09Ipgz_Aw3glaM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>274750009</pqid></control><display><type>article</type><title>Dietary trans fatty acids: Review of recent human studies and food industry responses</title><source>SpringerLink Contemporary</source><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Hunter, J. Edward</creator><creatorcontrib>Hunter, J. Edward</creatorcontrib><description>Dietary trans FA at sufficiently high levels have been found to increase low density lipoprotein (LDL)-cholesterol and decrease high density lipoprotein (HDL)-cholesterol (and thus to increase the ratio of LDL-cholesterol/HDL-cholesterol) compared with diets high in cis monounsaturated FA or PUFA. The dietary levels of trans FA at which these effects are easily measured are around 4% of energy or higher to increase LDL-cholesterol and around 5 to 6% of energy or higher to decrease HDL-cholesterol, compared with essentially trans-free control diets. Very limited data at lower levels of intake (less than 4% of energy) are available. Most health professional organizations and some govemments now recommend reduced consumption of foods containing trans FA, and effective January 1, 2006, the U.S. Food and Drug Administration requires the labeling of the amounts of trans FA fer serving in packaged foods. In response, the food industry is working on ways to eliminate or greatly reduce trans FA in food products. Current efforts focus on four technological options: (i) modification of the hydrogenation process, (ii) use of interesterification, (iii) use of fractions high in solids from natural oils, and (iv) use of trait-enhanced oils. Challenges to the food industry in replacing trans FA in foods are to develop formulation options that provide equivalent functionality, are economically feasible, and do not greatly increase saturated FA content.</description><identifier>ISSN: 0024-4201</identifier><identifier>EISSN: 1558-9307</identifier><identifier>DOI: 10.1007/s11745-006-5049-y</identifier><identifier>PMID: 17263298</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Animals ; Cardiovascular Diseases - epidemiology ; Cardiovascular Diseases - metabolism ; Cholesterol ; dietary fat ; Dietary Fats, Unsaturated - administration &amp; dosage ; Dietary Fats, Unsaturated - adverse effects ; Food Industry ; food supply ; Food Supply - standards ; heart diseases ; human health ; human nutrition ; Humans ; literature reviews ; neoplasms ; noninsulin-dependent diabetes mellitus ; Trans Fatty Acids - administration &amp; dosage ; Trans Fatty Acids - adverse effects ; Trans Fatty Acids - chemistry ; United States</subject><ispartof>Lipids, 2006-11, Vol.41 (11), p.967-992</ispartof><rights>2006 American Oil Chemists' Society (AOCS)</rights><rights>Copyright AOCS Press Nov 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353</citedby><cites>FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1644,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17263298$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hunter, J. Edward</creatorcontrib><title>Dietary trans fatty acids: Review of recent human studies and food industry responses</title><title>Lipids</title><addtitle>Lipids</addtitle><description>Dietary trans FA at sufficiently high levels have been found to increase low density lipoprotein (LDL)-cholesterol and decrease high density lipoprotein (HDL)-cholesterol (and thus to increase the ratio of LDL-cholesterol/HDL-cholesterol) compared with diets high in cis monounsaturated FA or PUFA. The dietary levels of trans FA at which these effects are easily measured are around 4% of energy or higher to increase LDL-cholesterol and around 5 to 6% of energy or higher to decrease HDL-cholesterol, compared with essentially trans-free control diets. Very limited data at lower levels of intake (less than 4% of energy) are available. Most health professional organizations and some govemments now recommend reduced consumption of foods containing trans FA, and effective January 1, 2006, the U.S. Food and Drug Administration requires the labeling of the amounts of trans FA fer serving in packaged foods. In response, the food industry is working on ways to eliminate or greatly reduce trans FA in food products. Current efforts focus on four technological options: (i) modification of the hydrogenation process, (ii) use of interesterification, (iii) use of fractions high in solids from natural oils, and (iv) use of trait-enhanced oils. Challenges to the food industry in replacing trans FA in foods are to develop formulation options that provide equivalent functionality, are economically feasible, and do not greatly increase saturated FA content.</description><subject>Animals</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cardiovascular Diseases - metabolism</subject><subject>Cholesterol</subject><subject>dietary fat</subject><subject>Dietary Fats, Unsaturated - administration &amp; dosage</subject><subject>Dietary Fats, Unsaturated - adverse effects</subject><subject>Food Industry</subject><subject>food supply</subject><subject>Food Supply - standards</subject><subject>heart diseases</subject><subject>human health</subject><subject>human nutrition</subject><subject>Humans</subject><subject>literature reviews</subject><subject>neoplasms</subject><subject>noninsulin-dependent diabetes mellitus</subject><subject>Trans Fatty Acids - administration &amp; dosage</subject><subject>Trans Fatty Acids - adverse effects</subject><subject>Trans Fatty Acids - chemistry</subject><subject>United States</subject><issn>0024-4201</issn><issn>1558-9307</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkc1rFDEYh4Modlv9A7xo8OBt9M3ka-KttFYLC4q655DJh6bszqx5Zyzz35syC4IXTyHwPD_CE0JeMHjLAPQ7ZEwL2QCoRoIwzfKIbJiUXWM46MdkA9CKRrTAzsg54l29MmHkU3LGdKt4a7oN2V3nOLmy0Km4AWly07RQ53PA9_Rr_J3jPR0TLdHHYaI_54MbKE5zyBGpGwJN4xhoHsKMU90oEY_jgBGfkSfJ7TE-P50XZHfz4fvVp2b7-ePt1eW28dx0uumlNwpSJx3nxkASxmjmvDMOotGh6xVTLe-F74PnOug2mOiDb6VQqk9c8gvyZt09lvHXHHGyh4w-7vduiOOMVnU1BNdQwdf_gHfjXIb6NttqoSUAmAqxFfJlRCwx2WPJhxrHMrAPwe0a3Nbg9iG4Xarz8jQ894cY_hqnwhXQK3Cf93H5_6Ld3n65BqN0NV-tZnKjdT9KRrv7Vj-TV09Ipgz_Aw3glaM</recordid><startdate>200611</startdate><enddate>200611</enddate><creator>Hunter, J. Edward</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springerā€Verlag</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>200611</creationdate><title>Dietary trans fatty acids: Review of recent human studies and food industry responses</title><author>Hunter, J. Edward</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cardiovascular Diseases - metabolism</topic><topic>Cholesterol</topic><topic>dietary fat</topic><topic>Dietary Fats, Unsaturated - administration &amp; dosage</topic><topic>Dietary Fats, Unsaturated - adverse effects</topic><topic>Food Industry</topic><topic>food supply</topic><topic>Food Supply - standards</topic><topic>heart diseases</topic><topic>human health</topic><topic>human nutrition</topic><topic>Humans</topic><topic>literature reviews</topic><topic>neoplasms</topic><topic>noninsulin-dependent diabetes mellitus</topic><topic>Trans Fatty Acids - administration &amp; dosage</topic><topic>Trans Fatty Acids - adverse effects</topic><topic>Trans Fatty Acids - chemistry</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hunter, J. Edward</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Earth, Atmospheric &amp; Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric &amp; Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Lipids</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hunter, J. Edward</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dietary trans fatty acids: Review of recent human studies and food industry responses</atitle><jtitle>Lipids</jtitle><addtitle>Lipids</addtitle><date>2006-11</date><risdate>2006</risdate><volume>41</volume><issue>11</issue><spage>967</spage><epage>992</epage><pages>967-992</pages><issn>0024-4201</issn><eissn>1558-9307</eissn><abstract>Dietary trans FA at sufficiently high levels have been found to increase low density lipoprotein (LDL)-cholesterol and decrease high density lipoprotein (HDL)-cholesterol (and thus to increase the ratio of LDL-cholesterol/HDL-cholesterol) compared with diets high in cis monounsaturated FA or PUFA. The dietary levels of trans FA at which these effects are easily measured are around 4% of energy or higher to increase LDL-cholesterol and around 5 to 6% of energy or higher to decrease HDL-cholesterol, compared with essentially trans-free control diets. Very limited data at lower levels of intake (less than 4% of energy) are available. Most health professional organizations and some govemments now recommend reduced consumption of foods containing trans FA, and effective January 1, 2006, the U.S. Food and Drug Administration requires the labeling of the amounts of trans FA fer serving in packaged foods. In response, the food industry is working on ways to eliminate or greatly reduce trans FA in food products. Current efforts focus on four technological options: (i) modification of the hydrogenation process, (ii) use of interesterification, (iii) use of fractions high in solids from natural oils, and (iv) use of trait-enhanced oils. Challenges to the food industry in replacing trans FA in foods are to develop formulation options that provide equivalent functionality, are economically feasible, and do not greatly increase saturated FA content.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>17263298</pmid><doi>10.1007/s11745-006-5049-y</doi><tpages>26</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-4201
ispartof Lipids, 2006-11, Vol.41 (11), p.967-992
issn 0024-4201
1558-9307
language eng
recordid cdi_proquest_miscellaneous_68307370
source SpringerLink Contemporary; Wiley-Blackwell Read & Publish Collection
subjects Animals
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - metabolism
Cholesterol
dietary fat
Dietary Fats, Unsaturated - administration & dosage
Dietary Fats, Unsaturated - adverse effects
Food Industry
food supply
Food Supply - standards
heart diseases
human health
human nutrition
Humans
literature reviews
neoplasms
noninsulin-dependent diabetes mellitus
Trans Fatty Acids - administration & dosage
Trans Fatty Acids - adverse effects
Trans Fatty Acids - chemistry
United States
title Dietary trans fatty acids: Review of recent human studies and food industry responses
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A38%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dietary%20trans%20fatty%20acids:%20Review%20of%20recent%20human%20studies%20and%20food%20industry%20responses&rft.jtitle=Lipids&rft.au=Hunter,%20J.%20Edward&rft.date=2006-11&rft.volume=41&rft.issue=11&rft.spage=967&rft.epage=992&rft.pages=967-992&rft.issn=0024-4201&rft.eissn=1558-9307&rft_id=info:doi/10.1007/s11745-006-5049-y&rft_dat=%3Cproquest_cross%3E68307370%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3987-b5c960f85a33990f49971aca9a0e97d8b61623b4cbdc37d72d9ecdc25466bf353%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=274750009&rft_id=info:pmid/17263298&rfr_iscdi=true